[go: up one dir, main page]

Bohe et al., 1983 - Google Patents

Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage

Bohe et al., 1983

Document ID
8496975199899862279
Author
Bohe M
Borgström A
Genell S
Ohlsson K
Publication year
Publication venue
Digestion

External Links

Snippet

The total daily amount of extractable cationic trypsin, chymotrypsin, and pancreatic elastase 2 in feces and ileostomy fluids has been studied in normal individuals and healthy colectomized subjects. Quantitation was performed using immunological assays with …
Continue reading at karger.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Similar Documents

Publication Publication Date Title
Bohe et al. Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage
JP4633926B2 (en) Methods and means for preventing or treating inflammation or pruritus
Befus et al. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells.
Fridhandler et al. Isolation and measurement of pancreatic amylase in human serum and urine
Doi et al. Adrenal renin: a possible regulator of aldosterone production
CA1308678C (en) Lipases and lipase extracts, their preparation process and their therapeutic use
Marcoullis et al. Cobalamin malabsorption due to nondegradation of R proteins in the human intestine. Inhibited cobalamin absorption in exocrine pancreatic dysfunction.
Goldberg et al. Fate of trypsin and chymotrypsin in the human small intestine
Lebenthal et al. Enterokinase and trypsin activities in pancreatic insufficiency and diseases of the small intestine
Sjölander et al. The effect of concanavalin A and wheat germ agglutinin on the ultrastructure and permeability of rat intestine: a possible model for an intestinal allergic reaction
Lee et al. Antithrombotic effects by oral administration of novel proteinase fraction from earthworm Eisenia andrei on venous thrombosis model in rats
Genell et al. Quantitation of active pancreatic endopeptidases in the intestinal contents of germfree and conventional rats
US20140275285A1 (en) Metadichol® liquid and gel nanoparticle formulations
Ihse et al. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy
Lewis et al. Effects of Epsilon Aminocaproic Acid on Coagulation and Fibrinolytic Mechanisms: Studies of epsilon aminocaproic acid therapy in cirrhotic patients without gross bleeding tendencies suggest that the low factor V levels found in liver disease are caused by decreased production, not by increased destruction
Durie et al. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction
Crabtree et al. Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.
Doubilet et al. Human biliary-pancreatic secretion.
Bohe et al. Metabolism of 131I-labelled human pancreatic cationic trypsin after intraduodenal administration
Kahn et al. Studies of the chemistry of pernicious anemia
Nakajima et al. Secretory characteristics of pancreatic γ-glutamyl transpeptidase
Iida et al. Characterization of Triton-solubilized TSH receptors from human thyroid plasma membranes
Moriyoshi et al. Fecal isoamylase activity in patients with pancreatic diseases
Loirat et al. Fulminant meningococcemia in a child with hereditary deficiency of the seventh component of complement and proteinuria
Kurosawa et al. Influence of bile flow obstruction vs bile diversion on pancreatic secretion in the conscious rat